Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol
Key facts
- Who runs it
- Beckman Coulter, Inc.
- Where
- Augusta, Cincinnati, Cleveland, Columbus, Hackensack, Indianapolis, Irvine, Kansas City, and Raleigh, United StatesSee the 10 sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 40,000 people, planned
- Started
- 15 Feb 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Record updated
- 21 June 2024
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- All races, ages and ethnicities
- All patients admitted to the hospital or presenting to the Emergency Department
Who cannot take part
- Patients not presenting to a hospital setting (e.g. urgent care, outpatient clinic excluded)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- Augusta University Medical SchoolAugusta, United StatesEnrolling by invitation
- University of CininnatiCincinnati, United StatesEnrolling by invitation
- MetroHealth SystemsCleveland, United StatesEnrolling by invitation
- The Ohio State UniversityColumbus, United StatesEnrolling by invitation
- Hackensack University Medical CenterHackensack, United StatesEnrolling by invitation
- Indiana University HealthIndianapolis, United StatesEnrolling by invitation
- University of California, IrvineIrvine, United StatesEnrolling by invitation
- University Health Truman Medical CenterKansas City, United StatesEnrolling by invitation
- University of Kansas Medical CenterKansas City, United StatesEnrolling by invitation
- WakeMed HealthRaleigh, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.
The group in the trial
- Primary Objective: Severe Sepsis
The primary endpoint for this study is defined as the presence of sufficient data for SOWS training and algorithm development to proceed with subsequent validation. To provide sufficient data subsets (severe sepsis EHR encounters) for training and validation of the Sepsis Onset Warning System algorithm. There will not be any interventions administered.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sepsis Onset Warning System [SOWS] Master Enrollment Study Protocol
- Fit questions
- Built from NCT05304728, who can take part
- Record updated
- 21 June 2024